Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use.
Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength.
Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate.
Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths.
Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg.
Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths.
The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.
Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths.
Mylan on Wednesday launched its celecoxib capsules in 50-, 100-, 200- and 400-mg dosage strengths. The drug is one of the first available generic versions of Celebrex capsules from Pfizer.
Greenstone announced the introduction of cabergoline tablets to its line of pharmaceutical products.